Pyrrole

Pyrrole

SCHEMBL29541024

[Co].c1cc[nH]c1.c1cc[nH]c1.c1cc[nH]c1.c1cc[nH]c1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyrrole SCHEMBL28881454 0.95
Pyrrole SCHEMBL28226554 0.95
Pyrrole SCHEMBL15801170 0.94
Pyrrole SCHEMBL841068 0.94
Pyrrole SCHEMBL14840876 0.94
Pyrrole SCHEMBL27535135 0.94
Pyrrole SCHEMBL2885785 0.94
Pyrrole SCHEMBL292 0.94
Pyrrole SCHEMBL15757584 0.94
Pyrrole SCHEMBL23327323 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230390414-A1 PARTICLE BASED FORMULATION OF SARS-COV-2 RECEPTOR BINDING DOMAIN UNIV NEW YORK STATE RES FOUND (US) 2023-12-07 US disclosed
EP-4221749-A1 PARTICLE BASED FORMULATIONS OF SARS-COV-2 RECEPTOR BINDING DOMAIN The Research Foundation for The State University of New York (US) 2023-08-09 EP disclosed
WO-2022072654-A1 PARTICLE BASED FORMULATIONS OF SARS-COV-2 RECEPTOR BINDING DOMAIN THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2022-04-07 WO disclosed